- FOR IMMEDIATE RELEASE
February 4, 2025 - Contact: Lara C. Kanitra
(202) 446-2028
lkanitra@neurosurgery.org
Neurosurgery Submits Comment to Senate Judiciary Hearing on Controlled Substances
Washington, DC—Today, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS), and seven other leading medical organizations sent a joint letter to Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Dick Durbin (D-Ill.) ahead of the Committee’s hearing titled, The Poisoning of America: Fentanyl, its Analogues, and the Need for Permanent Class Scheduling, scheduled for February 4, 2025. The hearing aims to examine the public health and safety threats posed by illicit fentanyl and its analogues and to evaluate the need for permanent class-wide scheduling of these substances under the Controlled Substances Act (CSA).
Click here to view the full Neurosurgery Submits Comment to Senate Judiciary Hearing on Controlled Substances.
